首页> 外文OA文献 >Correlation Between Quantitative HBsAg and HBV-DNA in Chronic Hepatitis B Infection
【2h】

Correlation Between Quantitative HBsAg and HBV-DNA in Chronic Hepatitis B Infection

机译:慢性乙型肝炎感染中HBsAg与HBV-DNA定量的相关性

摘要

Background: Methods used to diagnose and monitor chronic hepatitis B (CHB) by quantitation of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) levels is expensive. Cheaper laboratory test as an additional markeris needed, thus we studied serum quantitative HBsAg to be used as surrogate marker in CHB patients. This study was aimed to investigate correlation between serum quantitative HBsAg and HBV-DNA in CHB patients.Method: In this cross-sectional study, we enrolled 62 CHB patients between January 2010 and December 2012 who had quantitative HBsAg and HBV-DNA assays in a private laboratory at Denpasar. HBV-DNA was measured by real-time polymerase chain reaction and quantitative serum HBsAg was measured by chemiluminescent microparticle immunoassay (CMIA). Stastistical analysis was performed by Mann-Whitney and Spearman\u27s correlation.Results: Of 62 patients, most subjects were males (82.26%). Mean HBsAg titer of CHB in HBeAg positive and negative patients were 281,000 and 4,900 IU/mL, respectively; while mean HBV-DNA in HBeAg positiveand negative patients were 59,000,000 and 7,530,000 IU/mL, respectively. We found that quantitative HBsAg and HBV-DNA in HBeAg positive and HBeAg negative patients were statistically signi cant (p = 0.0001, p = 0.0001, respectively). Signi cant correlation was found between serum quantitative HBsAg and HBV-DNA (r = 0.737; p= 0.000). Quantitative HBsAg was signi cantly correlated with HBV-DNA in HBeAg-positive subgroup (r = 0.717; p = 0.0001); and signi cant correlation was also found in HBeAg-negative subgroup (r = 0.443; p = 0.006) although the correlation was weak. Conclusion: Quantitative HBsAg has signi cant correlation with HBV-DNA in CHB patients.
机译:背景:通过定量乙肝病毒-脱氧核糖核酸(HBV-DNA)水平来诊断和监测慢性乙肝(CHB)的方法非常昂贵。需要更便宜的实验室测试作为附加标志物,因此我们研究了血清定量HBsAg作为CHB患者的替代标志物。该研究旨在调查CHB患者血清HBsAg与HBV-DNA的相关性。方法:在本横断面研究中,我们纳入了2010年1月至2012年12月之间在HBsAg和HBV-DNA定量检测中的62例CHB患者。登巴萨的私人实验室。通过实时聚合酶链反应测量HBV-DNA,通过化学发光微粒免疫法(CMIA)测量血清HBsAg的含量。通过Mann-Whitney和Spearman的相关性进行统计学分析。结果:62例患者中,大多数受试者为男性(82.26%)。在HBeAg阳性和阴性患者中,CHB的平均HBsAg滴度分别为281,000和4,900 IU / mL;而HBeAg阳性和阴性患者的平均HBV-DNA分别为59,000,000和7,530,000 IU / mL。我们发现HBeAg阳性和HBeAg阴性患者的定量HBsAg和HBV-DNA具有统计学显着性(分别为p = 0.0001,p = 0.0001)。在血清定量HBsAg和HBV-DNA之间发现显着相关性(r = 0.737; p = 0.000)。在HBeAg阳性亚组中,HBsAg的定量与HBV-DNA显着相关(r = 0.717; p = 0.0001);尽管相关性较弱,但在HBeAg阴性亚组中也发现了显着相关性(r = 0.443; p = 0.006)。结论:CHB患者体内HBsAg的定量与HBV-DNA无显着相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号